معرفی
Charlotte Beaudart is a researcher at the Namur Research Institute for Life Sciences, University of Namur, affiliated with the Unité de recherche en pharmacologie et toxicologie clinique. She holds a Doctor of Health Science from the Université de Liège, focusing on sarcopenia. Her work spans geriatric medicine, osteoporosis, aging, and public health epidemiology.
- Doctor of Health Science, Université de Liège (2016)
Her research focuses on sarcopenia, osteoporosis, muscle health in aging, and systematic reviews/meta-analyses in clinical geriatrics. She investigates patient risk factors, diagnostic tools, and treatment outcomes, contributing significantly to evidence-based geriatric care. Her work aligns with UN Sustainable Development Goals on health and well-being.
The recent articles show a strong trend in systematic reviews and meta-analyses applied to geriatric conditions, particularly sarcopenia and osteoporosis. Topics include fracture risk prediction, PTH1 agonists, cardiac toxicity in cancer therapy, and gender equity in treatment. The research emphasizes methodological rigor and clinical applicability.
Her scientific awards include:
- AstraZeneca FRS-FNRS Award (2023)
- Best oral communication, Journées d’Automne de la SBGG (2015)
- Best poster communication, JASFGG (2014)
- Best poster - 11ème Congrès International Francophone de Gérontologie et Gériatrie (2018)
- Best Publication of the year 2015 - Belgian Bone Club
She advises students and researchers, with at least one supervised work recorded. She leads the PHARE research group and contributes to projects on microplastics and osteoporosis. Her external engagements include committee memberships in the Belgian Bone Club and the European Geriatric Medicine Society. She frequently presents at conferences and contributes to editorial activities.
She is actively involved in research networks focusing on aging, public health, and clinical epidemiology, with collaborations across Belgium and internationally.
